Preclinical studies have demonstrated that BRAF plays an important role in regulating the mitogen-activated protein kinases (MAPK) signaling cascade by promoting proliferation, survival, and invasion of melanoma cells [8]–[14]. The gene discussed is WNK2; the disease is melanoma.